drug terminology efforts in hl7
DESCRIPTION
Evaluation of a Proposed Method for Representing Drug Terminology James J. Cimino, Timothy J. McNamara, Terri Meredith, Carol A. Broverman, Karen C. Eckert. Drug Terminology Efforts in HL7. Need for medication terms Much source data generated by pharmacy systems - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/1.jpg)
Evaluation of a Proposed Method for Representing Drug Terminology
James J. Cimino, Timothy J. McNamara, Terri Meredith, Carol A. Broverman,
Karen C. Eckert
![Page 2: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/2.jpg)
Drug Terminology Efforts in HL7
• Need for medication terms
• Much source data generated by pharmacy systems
• Pharmacy knowledge base vendors are exploring ways to place their terminologies in the public domain
• Vocabulary TC convened meetings to explore ways of collaborating
![Page 3: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/3.jpg)
Disclaimer
• Nothing is a balloted standard yet
• TC has not yet proposed a formal model
• TC has not yet proposed a plan of action
• TC is still defining scope and goals
![Page 4: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/4.jpg)
Drug Model Hierarchy
Drug Class
Not-Fully-Specified Drug
Clinical Drug
Trademark Drug
Manufactured Components
Ingredient Class
International Package Identifiers
Country-Specific Packaged Product
Ingredient
is-a
is-a
is-a
is-a
is-a
is-a
Chemicals
MedicationsPackages
Composite Clinical Drug
is-a
Composite Trademark Drug
is-a
![Page 5: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/5.jpg)
Drug Model Hierarchy
Drug Class
Not-Fully-Specified Drug
Trademark Drug
Manufactured Components
Ingredient Class
International Package Identifiers
Country-Specific Packaged Product
Ingredient
is-a
is-a
is-a
is-a
is-a
is-a
Chemicals
MedicationsPackages
Composite Clinical Drug
is-a
Composite Trademark Drug
is-a
Clinical Drug
![Page 6: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/6.jpg)
Clinical Drugs
• Dosage form
• Active ingredients– Chemical
– Form Strength• Strength amount
• Strength units
• Volume
• Volume units
![Page 7: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/7.jpg)
Experiment
• Can model allow for interoperability?– Single terminology vs.– Mapping between terminologies
• Select random sample of drug terms
• Obtain descriptions from terminology developers
• Compare description components
• Examine overall match rate
![Page 8: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/8.jpg)
Sample Selection
• 71,000 NDC Codes
• 1000 selected at random (1.4%)
• Many are obsolete
![Page 9: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/9.jpg)
Descriptions from Vendors
Name Form Ingredient 1 Ingredient 2
Valium 5mg Tablet Tablet Diazepam ^5^mg
Tylenol #3 Tablet Acetaminophen Codeine ^325^mg ^30^mg
Chloral Hydrate Syrup Syrup Chloral Hydrate 100.000000^mg^1.000000^ml
![Page 10: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/10.jpg)
Descriptions from Vendors
Set Mapped
A 358
B 459
C 605
D 405
E 566
A B C D E None
- 340 358 326 357 642
340 - 452 361 449 541
358 452 - 393 554 395
326 361 393 - 392 395
357 449 554 392 - 434
Overall, 367 terms were not represented in any set, 71 appeared in only one set, 77 appeared in exactly two sets, 83 appeared in three sets, 91 appeared in four, and 311 terms appeared in all five terminologies.
![Page 11: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/11.jpg)
Pairwise Comparisons
Set B C D E
A 340 358 326 357
B 452 361 449
C 393 554
D 392
E
![Page 12: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/12.jpg)
Pairwise Comparisons
Set B C D E
A 340 358 326 357
B 452 361 449
C 393 554
D 392
E
{3982
![Page 13: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/13.jpg)
Comparisons
• Dosage Form: 3982
• Ingredient (number and match): 5507
• Dose Strength (dose, units, volume, volume units): 4337
• Overall: 3982
![Page 14: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/14.jpg)
Dosage Form Matching
• TAB = TABLET
• LIQUID ORAL LIQUID
• 111 Dosage form synonyms
![Page 15: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/15.jpg)
Ingredient Matching
• HCl vs. Hydrochloride
• Salt vs. Base
• Inclusion of form or route
• Mention of animal source
![Page 16: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/16.jpg)
Dose Strength Matching
• Standard format (000050000 vs. 500.00)
• Normalization of units (GM vs. MG)
![Page 17: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/17.jpg)
Dose Units Matching
• Standard abbreviations
• Normalization of units (GM vs. MG)
• Missing values
• Inclusion of concentration information
• MG vs. %
![Page 18: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/18.jpg)
Dose Volume Matching
• Not given
• Different numeric formats
• Defaults (0 and 1)
• Different volumes ( per 1ml vs per 5ml)
![Page 19: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/19.jpg)
Dose Volume Units Matching
• Not given
• “Each”
• Different abbreviations
![Page 20: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/20.jpg)
Overall Matching
• Form matches
• Same number of ingredients
• Each ingredient matches on chemical and all four other parameters
![Page 21: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/21.jpg)
Overall Matching
Total Before After Conversion Conversion Components: Ingredients 5507 3607 (65%) 4337 (79%) Strength 4337 374 (9%) 3262 (75%) Units 4337 1845 (43%) 2964 (68%) Volume 4337 1054 (24%) 3754 (87%) Volume Units 4337 2319 (53%) 3486 (80%)
Components:
Overall: Each Ingred 4337 0 (0%) 2773 (64%) All Ingred 3982 0 (0%) 2519 (63%) Dose Form 3982 645 (16%) 2859 (72%) Complete Drug 3982 0 (0%) 2128 (53%)53%
![Page 22: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/22.jpg)
Pairwise Comparisons
Set A B C D E
A - 340 358 326 357
B 340 - 452 361 449
C 358 452 - 393 554
D 326 361 393 - 392
E 357 449 554 392 -
![Page 23: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/23.jpg)
Set A B C D E
A - 59% 45% 48% 52%
B 59% - 54% 63% 62%
C 45% 54% - 46% 48%
D 48% 63% 46% - 58%
E 52% 62% 48% 58% -
Pairwise Complete Matches
![Page 24: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/24.jpg)
Example of MismatchGUAIFENESIN AC LIQUID|10;100|MG/5ML;MG/|LIQUID
SYRUP|GUAIFENESIN^00000000.000^^0000.000^CODEINE PHOSPHATE^.^^.^
LIQUID|CODEINE PHOSPHATE^2.000000^MG^^GUAIFENESIN^20.000000^MG^1.000000^ML
LIQUID, ORAL (SYSTEMIC)|CODEINE PHOSPHATE^10^MG^5^MLGUAIFENESIN^100^MG^5^ML
LIQUID|CODEINE PHOSPHATE^10.0000^MG/5ML^^GUAIFENESIN^100.0000^MG/5ML^^
SYRUP|CODEINE PHOSPHATE^10^MILLIGRAM(S)^5^MILLILITER(S)GUAIFENESIN^100^MILLIGRAM(S)^5^MILLILITER(S)
![Page 25: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/25.jpg)
Example of Mismatch
BUMEX INJECTION|0.25|MG|INJ-SOL
AMPUL
BUMETANIDE^00000000.250^MG^0001.000^ML
INJECTION
SODIUM CHLORIDE, IV USE^0.850000^%^^
BUMETANIDE, INJECTABLE^0.250000^MG^1.000000^ML
INJECTION
BUMETANIDE^0.25^MG^1^ML
SOLUTION
BUMETANIDE^0.2500^MG/ML^^
SOLUTION
BUMETANIDE^0.25^MILLIGRAM(S)^1^MILLILITER(S)
![Page 26: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/26.jpg)
Example of Mismatch
RECOMBIVAX HB ADULT FORMULATION INJECTION|10|MCG|INJ-SUS
VIAL
HEPATITIS B VIRUS VACCINE^00000010.000^MCG^0001.000^ML
INJECTION
HEPATITIS B SURFACE ANTIGEN^10.000000^MCG^1.000000^ML
INJECTION
HEPATITIS B VACCINE-RECOMBINANT^10^MCG^1^ML
INJECTION
HEPATITIS B VIRUS VACCINE RECOMBINANT^10.0000^MCG/ML ^^
SOLUTION
HEPATITIS B VACCINE RECOMBINANT^10^MICROGRAM(S)^ 1^MILLILITER(S)
![Page 27: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/27.jpg)
Focus on Dosage Form
• 3982 comparisons
• 111 synonyms
• 72% match rate
• What went wrong?
![Page 28: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/28.jpg)
Examination of Dosage Forms
• Compare use of each form, in each source, with use in other sources for corresponding medications
• Look for irregularities in source
• Look for 100% agreement
• When not 100% agreement, look at hierarchical subsumption
![Page 29: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/29.jpg)
Irregularities in Sources
NDC: 0000153144|FLUORITAB TABLETS CHEWABLE CHERRY|1.1|MG| TAB CHEW|100|BOT:
A:: |FLUORITAB 0.5MG TABLET CHEW^SODIUM FLUORIDE| CHEWABLE TABLET|SODIUM FLUORIDE^00000000.500^MG ^0000.000^
B: |FLUORITAB CHERRY TABS CHEW, 0.5MG|CHEWABLE TABLET| SODIUM FLUORIDE^1.100000^MG^^
C: |SODIUM FLUORIDE CHEW TAB 1.1 MG (0.5MG F)|CHEWABLE TABLET|SODIUM FLUORIDE^1.1000^MG^^
D: ||TABLET|SODIUM FLUORIDE^0.5^MG^^
![Page 30: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/30.jpg)
Near Misses and the Hierarchy
ASodium Fluoride1.1 MGChewable TabletB
C
D
Tablet
ChewableTablet
is-a
is-a
Sodium Fluoride1.1 MGTablet
![Page 31: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/31.jpg)
Irregularities in Sources
NDC: 0000014889|PROPRANOLOL HYDROCHLORIDE EXTENDED RELEASE CAPSULES|80|MG|CAP ER|100|BOT
A: ||CAPSULE CR|PROPRANOLOL HYDROCHLORIDE^80^MG^^
B: |PROPRANOLOL 80MG CAPSULE SA^PROPRANOLOL HCL| CAPSULE CR|PROPRANOLOL HCL^00000080.000^MG^0000.000^
C:: |PROPRANOLOL HCL CAP CR 80 MG|CAPSULE CR| PROPRANOLOL HYDROCHLORIDE^80.0000^MG^^
D:: |PROPRANOLOL HYDROCHLORIDE^80 MG|CAPSULE CR| PROPRANOLOL HYDROCHLORIDE^80^MILLIGRAM(S)^1^EACH
E:: |PROPRANOLOL HCL TABS CR, 80MG|TABLET CR|PROPRANOLOL HYDROCHLORIDE^80.000000^MG^^
![Page 32: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/32.jpg)
Example of 100% Agreement
A: LOTION: 1: LOTION|
B: LOTION: 1: LOTION|
C: LOTION: 1: LOTION|
D: LOTION: 1: LOTION|
E: LOTION: 1: LOTION|
![Page 33: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/33.jpg)
Example of 100% Agreement
A: TABLET CR: 14: TAB E REL|TAB FC ER
B: TABLET CR: 6: TAB FC ER|TAB SUG CO|
C: TABLET CR: 9: TAB FC ER|TAB E REL|
D: TABLET CR: 14: TAB E REL|TAB FC ER|TAB FC|
E: TABLET CR: 7: TAB FC ER|TAB E REL|
![Page 34: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/34.jpg)
Example of <100% Agreement
A: AEROSOL: 2: INHALANT|AEROSL SPR|
B: AEROSOL: 1: INHALANT|
C: AEROSOL: 1: INHALANT| SPRAY, TOPICAL, DERMAL: 1: AEROSL SPR|
D: AEROSOL: 2: INHALANT|AEROSL SPR|
E: AEROSOL: 1: INHALANT|
![Page 35: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/35.jpg)
Handling Ambiguity
Aerosol
InhaledAerosol
is-a
DermalAerosol
A
Triamcinolone Acetonide0.147mg/GMAerosol
A
Terbutaline Sulfate0.2mg/ACTAerosol
D
Terbutaline Sulfate0.2mg/ACTInhaled Aerosol
C
E
B
C
Triamcinolone Acetonide0.147mg/GMDermal Aerosol
is-a is-a
![Page 36: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/36.jpg)
Example of Subsumption
Aerosol ():A(AEROSOL) D(AEROSOL)
Inhaled Aerosol (INHALENT):B(AEROSOL) C(AEROSOL)
E(AEROSOL)
Dermal Aerosol (AEROSL SPR): C(SPRAY TOPICAL, DERMAL)
![Page 37: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/37.jpg)
No Solution for SolutionAMPULDROPSINFUS. BTLINJECTIONIRRIGATION SOLUTIONIV SOLN.KITPIGGYBACKPLAST. BAGSKIN TESTSOLUTIONSYRUPVIAL
ELIXIRINJ REPOSITORYINJECTIONINJECTION TYPEINJECTION IVPBKITLIQUIDSOLUTIONSUSPENSION
DROPS, OPHTHALMIC (NON-SYSTEMIC)INJECTIONIRRIGATION SOLUTIONKIT, INJECTION (SYSTEMIC)SOLUTION FOR DROPS, OTICSOLUTION FOR INHALATION...SOLUTION OPHTMALMIC…SOLUTION, ORAL (SYSTEMIC)SOLUTION, OTICSOLUTION, TOPICAL, DERMALSYRUP
CONCENTRATEINJECTIONKITNEBUOILSOLUTIONSYRUP
![Page 38: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/38.jpg)
Discussion
• Matching is still far from perfect
• Not surprising, given lack of standards for attribute values
• Next steps
![Page 39: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/39.jpg)
Discussion: Next Steps
• Define some rules for each field
• Select new random sample
• Find subset with good overlap across terminologies
• Submit descriptions of new subset
![Page 40: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/40.jpg)
Discussion: New Rules
• Dose forms: separate translation step• Ingredients:
– Right number– Specific chemical entity– Identifiers (UMLS?)– Don’t mix in route or concentration
• Strengths:– Conversion algorithms– Rules for defaults– Don’t mix route or concentration with strength
![Page 41: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/41.jpg)
Conclusions
• Glass half empty:– How can we do automated translation of patient
data?– Can drug order transfers and decision support
be safe?
• Glass half full:– No attempt yet to standardize attribute
terminology– Most translation was much better than 50%– Just getting started– Better than what we do now
![Page 42: Drug Terminology Efforts in HL7](https://reader036.vdocument.in/reader036/viewer/2022070411/568148e5550346895db5ff39/html5/thumbnails/42.jpg)